Sunshine Biopharma Inc. Debt Instrument, Decrease, Forgiveness
Sunshine Biopharma Inc. (SBFM) reported Debt Instrument, Decrease, Forgiveness of $10.51 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Notes › Debt › Debt Instruments › Debt Instrument, Increase (Decrease), Net
us-gaap:DebtInstrumentDecreaseForgiveness · last filed 2021-03-30
- Sunshine Biopharma Inc. debt instrument, decrease, forgiveness for the quarter ending 2018-12-31 was $0.00.
- Sunshine Biopharma Inc. debt instrument, decrease, forgiveness for the quarter ending 2018-09-30 was $0.00.
- Sunshine Biopharma Inc. debt instrument, decrease, forgiveness for the quarter ending 2017-12-31 was $0.00.
- Sunshine Biopharma Inc. debt instrument, decrease, forgiveness for the quarter ending 2017-09-30 was $0.00.
- Sunshine Biopharma Inc. debt instrument, decrease, forgiveness for fiscal 2020 was $10.51K.
- Sunshine Biopharma Inc. debt instrument, decrease, forgiveness for fiscal 2019 was -$9.33K.
- Sunshine Biopharma Inc. debt instrument, decrease, forgiveness for fiscal 2018 was -$247.00.
- Sunshine Biopharma Inc. debt instrument, decrease, forgiveness for fiscal 2017 was $0.00.
| Period end | Debt Instrument, Decrease, Forgiveness 3 month | Debt Instrument, Decrease, Forgiveness 6 month | Debt Instrument, Decrease, Forgiveness 9 month | Debt Instrument, Decrease, Forgiveness 12 month |
|---|---|---|---|---|
| 2020-12-31 | $10.51K 10-K · filed 2021-03-30 | |||
| 2019-12-31 | -$9.33K 10-K · filed 2021-03-30 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-01 | $0.00 derived: sum of 2 quarters · filed 2020-05-01 | -$247.00 10-K · filed 2020-05-01 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | -$247.00 10-Q · filed 2018-11-16 | ||
| 2018-06-30 | -$247.00 10-Q · filed 2018-08-17 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-12 | $0.00 derived: sum of 2 quarters · filed 2019-04-12 | $0.00 10-K · filed 2019-04-12 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16 | $0.00 10-Q · filed 2018-11-16 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-17 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$1.31K 10-K · filed 2018-04-02 | ||
| 2016-09-30 | -$1.31K 10-Q · filed 2017-11-15 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | $0.00 10-K · filed 2017-04-17 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |